Sartorius integrates online biomass measurement to its ambr systems for microbial applications
Scientists to rapidly obtain detailed process understanding and control over their microbial cultures.
Sartorius Stedim Biotech (SSB) is introducing integrated online biomass measurement to its ambr 15 fermentation and ambr 250 high throughput systems for microbial applications.
Already well known in the industry for fast-tracking microbial screening studies and shortening process development timelines, the ambr 15 fermentation and ambr 250 high throughput systems operate up to 24 single-use stirred bioreactor cultures in parallel. With the integration of online biomass measurement, SSB has addressed the bottleneck associated with offline sampling. The new online biomass capability features state-of-the-art non-invasive reflectance measurement, saving time, effort and sample volume. It enables scientists to rapidly obtain detailed process understanding and control over their microbial cultures.
Online biomass measurement provides real-time non-invasive, continuous growth monitoring of 24 microbial cultures running in parallel. The reflectance-based technology means that sampling is not required. Instead, it uses lasers to transmit light through the base of each bioreactor and microprocessors to translate this into a reflectance measurement. With a wide dynamic measurement range, and bubble correction factors to take into account gas bubble density, reliable online measurements can be achieved even in high aeration and agitation environments. Through a user calibration process, online reflectance can be displayed as online optical density (OD), wet cell weight (WCW) or dry cell weight (DCW). To date, the online biomass measurement has been successfully tested with different organisms including E.coli, Pichia pastoris, Saccharomyces cerevisiae, Streptomyces spp. and Corynebacterium spp.
“Fermentation scientists often have to perform time-consuming sampling to monitor growth and initiate process control based on offline data. Sample preparation and manual data handling can introduce variability and errors; it may also necessitate samples being taken at unsociable hours or over weekends,” explained Alison Rees-Manley, ambr 15 Product Manager at SSB. “By integrating innovative biomass monitoring technology into our ambr systems for microbial applications, we enable real-time growth data to be used for more advanced process control. We’re confident that these ambr systems will help scientists by reducing the burden of offline sampling and providing better process understanding and greater control of microbial cultures. This will result in more accurate and predictive data for cost-efficient protein production,” she added.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance